简短版中医健康量表和欧洲五维健康量表在脑卒中患者中的测量特性评价

doi:10.3969/j.issn.1006-7795.2019.04.024

首都医科大学学报 ›› 2019, Vol. 40 ›› Issue (4): 627-634.doi: 10.3969/j.issn.1006-7795.2019.04.024

简短版中医健康量表和欧洲五维健康量表在脑卒中患者中的测量特性评价

戴琳¹, 温玉成², 路桃影³, 蔡坚雄³, 王立新⁴, 秦敏⁵, 吴大嵘³

1. 广州中医药大学第二临床医学院, 广州 510405;
2. 东莞市东城医院, 东莞 523000;
3. 广州中医药大学第二附属医院中医临床结局评价团队, 广州 510120;
4. 广东省中医院神经内科, 广州 510120;
5. 广东省第二中医医院针灸康复科, 广州 510095

收稿日期:2019-04-22 出版日期:2019-07-21 发布日期:2019-07-19
通讯作者: 吴大嵘 E-mail:darongwu@163.com
基金资助:
国家重点研发计划（2018YFC1706006），广东省中医院中医药科学技术研究专项（YN2015QN13），广东省中医院临床路径专项（中医二院《2015》119号）。

Measurement characteristics evaluation of SF-HSTCM and EQ-5D-3L among patients with stroke

Dai Lin¹, Wen Yucheng², Lu Taoying³, Cai Jianxiong³, Wang Lixin⁴, Qin Min⁵, Wu Darong³

1. The Second Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou 510405;
2. The Hospital of Dongguan Dongcheng, Dongguan 523000, Guangdong Province, China;
3. Program for Outcome Assessment in TCM, 2nd Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China;
4. Department of Neurology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, China;
5. Department of Acupuncture and Rehabilitation, Guangdong Second TCM Hospital, Guangzhou 510095, China

Received:2019-04-22 Online:2019-07-21 Published:2019-07-19
Supported by:
This study was supported by Key Research and Development Program of China (2018YFC1706006),The Special Fund of Research on Traditional Chinese Medicine Science and Technology of Guangdong Provincial Hospital of Chinese Medicine(YN2015QN13),Clinical Pathway Project of Guangdong Provincial Hospital of Chinese Medicine(Zhong Yi Er Yuan, 2015, No.119).

摘要/Abstract

摘要： 目的评估简短版中医健康量表（The Short Form-Health Scale of Traditional Chinese Medicine，SF-HSTCM）和欧洲五维健康量表（The Three-level EuroQol Five-dimensional Questionnaire，EQ-5D-3L）在脑卒中恢复期患者中的测量特性及其适用性。方法本研究采用横断面调查的方法，以脑卒中恢复期的患者为研究对象，调查的问卷包括SF-HSTCM、EQ-5D-3L、改良Rankin量表（Modified Rankin Scale，mRS）和巴氏量表（Barthel Index，BI）。统计学方法主要包括用Cronbach's α系数及验证性因子分析分别评估SF-HSTCM的信度及效度，组内相关系数评估SF-HSTCM、EQ-5D-3L、mRS和BI的重测信度及患者与代理人之间一致性信度，而会聚效度用SF-HSTCM与EQ-5D-3L之间的相关程度来进行评价，并采用非参数检验评估SF-HSTCM的区分效度，多重线性回归的方法分析社会人口学因素对于BI、mRS得分的影响。结果共205人完成了调查，SF-HSTCM在脑卒中恢复期患者中的内在一致性Cronbach's α系数为0.895，重测信度组内相关系数为0.991；EQ-5D-3L的重测信度结果显示两次调查完全一致的问卷数占总数的90%。结论 SF-HSTCM及EQ-5D-3L均可应用于脑卒中恢复期人群的健康状态评测。

关键词: 脑卒中, 信度, 效度, 简短版中医健康量表, 欧洲五维健康量表

Abstract: Objective To evaluate the measurement characteristics and applicability of The Short Form-Health Scale of Traditional Chinese Medicine (SF-HSTCM) and The Three-level EuroQol Five-dimensional Questionnaire (EQ-5D-3L) for patients recovering from stroke. Methods The study followed a cross-sectional design. We investigated patients with stroke on the recovery stage. Questionnaires applied in the study included SF-HSTCM, EQ-5D-3L, Modified Rankin Scale (mRS) and Barthel Index (BI). We analyzed the reliability and validity of SF-HSTCM by the Cronbach's alpha coefficient and confirmatory factor, test-retest reliability of SF-HSTCM,EQ-5D-3L,mRS and BI,and consistency coefficient between patients and agent by interclass correlation coefficient, correlation between SF-HSTCM and EQ-5D-3L by convergent validity, discriminant validity of SF-HSTCM by nonparametric test. The impact of Social and demographic factors on score of BI and mRS was evaluated by multiple linear regression.Results A total of 205 people were investigated. The internal consistency of Cronbach's α among patients with stroke in the recovery phase was 0.895, intercorrelation coefficient of test-Retest reliability was 0.991. The test-retest reliability result of EQ-5D-3L showed that questionnaires of two surveys which was exactly the same,accounting for 90% of the total number. Conclusion SF-HSTCM and EQ-5D-3L can be used to evaluate the health status of the patients with stroke in the recovery phase.

Key words: stroke, reliability, validity, The Short Form-Health Scale of Traditional Chinese Medicine(SF-HSTCM), The Three-level EuroQol Five-dimensional Questionnaire(EQ-5D-3L)

中图分类号:

R743.3

戴琳, 温玉成, 路桃影, 蔡坚雄, 王立新, 秦敏, 吴大嵘. 简短版中医健康量表和欧洲五维健康量表在脑卒中患者中的测量特性评价[J]. 首都医科大学学报, 2019, 40(4): 627-634.

Dai Lin, Wen Yucheng, Lu Taoying, Cai Jianxiong, Wang Lixin, Qin Min, Wu Darong. Measurement characteristics evaluation of SF-HSTCM and EQ-5D-3L among patients with stroke[J]. Journal of Capital Medical University, 2019, 40(4): 627-634.

参考文献 16

[1]	Liu Z,Zhou X,Zhang W,et al. Factors associated with quality of life early after ischemic stroke:the role of resilience[J].2019,8:1-7
[2]	Kwon S, Park J H, Kim W S,et al. Health-related quality of life and related factors in stroke survivors:Data from Korea National Health and Nutrition Examination Survey (KNHANES) 2008 to 2014[J].PLoS One, 2018,13(4):e0195713.
[3]	Kreimeier S, Oppe M, Ramos-Goñi J M,et al.Valuation of EuroQol Five-Dimensional Questionnaire, Youth Version (EQ-5D-Y) and EuroQol Five-Dimensional Questionnaire, Three-Level Version (EQ-5D-3L) Health States:the impact of wording and perspective[J].Value Health,2018,21(11):1291-1298.
[4]	Golicki D, Niewada M, Karlińska A,et al.Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients[J].Qual Life Res,2015,24(6):1555-1563.
[5]	吴大嵘,赖世隆,郭新峰,等.中医健康量表的建立和初步评价[J].中国中西医结合杂志,2007,27(9):847-850.
[6]	Wu D, Lai S,Zhou L,et al.Further validation of the health scale of traditional Chinese medicine (HSTCM)[J].Chin Med,2009,4:8.
[7]	王维治,万琪,刘恩重,等.神经病学[M].北京:人民卫生出版社,2006:99-100.
[8]	杜旭东,朱萍,李宓儿,等.EQ-5D和SF-6D测量脑卒中患者健康效用值的比较[J].四川大学学报(医学版),2018,49(2):252-257.
[9]	冉孟冬,刘冰清,陈龙妹,等.EQ-5D和SF-12评价脑卒中患者生命质量的比较[J].四川大学学报(医学版),2015,46(1):94-98.
[10]	Cadilhac D A,Kilkenny M F,Lannin N A,et al. Outcomes for patients with in-hospital stroke:a multicenter study from the australian stroke clinical registry (AuSCR)[J].J Stroke Cerebrovasc Dis,2019,28(5):1302-1310.
[11]	卢星.人工耳蜗植入儿童听觉言语能力及健康相关生活质量研究[D].郑州:郑州大学,2018.
[12]	王明航,李晓俊,陈学昂,等.慢性阻塞性肺疾病急性加重风险预警体系专家调查[J].中医杂志,2018,59(20):1735-1741.
[13]	于长禾,孙亚男,何丽云,等.中医普适性生活质量量表的系统评价[J].中华中医药杂志,2016,31(2):432-437.
[14]	王英,王小艺,冯晓远,等.中医生命质量量表研究现状[J].中华中医药杂志,2017,32(7):3270-3272.
[15]	Hou L,Du X,Chen L,et al.Exercise and quality of life after first-ever ischaemic stroke:a two-year follow-up study[J].Int J Neurosci,2018,128(6):540-548.
[16]	Kim E S, Kim J W, Kang H J, et al.Longitudinal Impact of depression on quality of life in stroke patients[J].Psychiatry Investig,2018,15(2):141-146.)[

简短版中医健康量表和欧洲五维健康量表在脑卒中患者中的测量特性评价

Measurement characteristics evaluation of SF-HSTCM and EQ-5D-3L among patients with stroke

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 16

相关文章 15

编辑推荐

Metrics

本文评价

[1]	徐建可, 刘宁, 韩苗, 张洪阳, 韩新生. 缺血性脑卒中患者颈动脉斑块性质与非高密度脂蛋白胆固醇浓度的相关性[J]. 首都医科大学学报, 2023, 44(1): 49-53.
[2]	秦琳慧, 李宁, 杨宇, 杨勇, 任长虹. 肢体远隔缺血期适应联合后适应促进大鼠缺血性脑卒中模型神经发生的作用及机制[J]. 首都医科大学学报, 2023, 44(1): 54-61.
[3]	姜富城, 黄菊梅, 冯跃先, 钟红亮, 贾建文, 杨洪超, 刘赫, 刘扬. 清醒镇静在急性缺血性脑卒中血管内治疗中的应用效果及预后影响评估[J]. 首都医科大学学报, 2023, 44(1): 72-77.
[4]	李森, 郭学文, 赵鑫, 黄安琪, 林婧格, 李兴茂, 李秀, 杜怡峰, 赵咏梅, 白洁, 夏章勇. 急性缺血性脑卒中合并糖尿病人群的血糖变异性与神经功能恶化的相关性分析[J]. 首都医科大学学报, 2023, 44(1): 78-84.
[5]	赵继宗. 我国脑心血管共患疾病现状与临床研究[J]. 首都医科大学学报, 2022, 43(5): 671-673.
[6]	谷强, 余孝君, 张津. 高龄与中低龄老年轻型缺血性脑卒中临床特点及预后分析[J]. 首都医科大学学报, 2022, 43(3): 474-479.
[7]	赵文博, 任长虹, 李思颉, 马红蕊, 吉训明. 低氧与缺血适应防治缺血性脑卒中新技术体系的创研及推广应用——2020年度国家科学技术进步奖二等奖[J]. 首都医科大学学报, 2022, 43(1): 1-5.
[8]	张凌燕, 阮祥燕, 李星明, 崔亚美, 谷牧青, 刘玉兰, 甄洁. 更年期症状全面评估量表的信度与效度评价[J]. 首都医科大学学报, 2021, 42(4): 511-520.
[9]	刘怡均, 林向英, 张燕. 中文版世界卫生组织生存质量测定量表简表用于终末期肾病的信效度验证[J]. 首都医科大学学报, 2021, 42(4): 635-641.
[10]	王璇, 马重阳, 张雅文, 程宏发, 张秋霞. 基于网络药理学的侯氏黑散抗缺血性脑卒中机制研究[J]. 首都医科大学学报, 2021, 42(1): 43-52.
[11]	张颖彬, 莫林宏, 聂忆秋, 刘爱贤. 近红外脑功能成像在重复经颅磁刺激治疗脑卒中后轻度认知功能障碍的应用[J]. 首都医科大学学报, 2020, 41(6): 965-969.
[12]	李明, 李思颉, 吴川杰, 赵文博, 顾超雄, 吉训明. 聚焦临床问题推动科技转化——吉训明教授[J]. 首都医科大学学报, 2020, 41(5): 748-751.
[13]	王菲, 刘海杰, 杨佳, 刘峥, 郝峻巍. 神经免疫之峰的攀登者——郝峻巍教授[J]. 首都医科大学学报, 2020, 41(5): 763-767.
[14]	单艺, 李静, 许潇尹. 缺血性脑卒中的脑功能与分子成像研究——卢洁教授[J]. 首都医科大学学报, 2020, 41(5): 788-794.
[15]	国家卫生健康委脑卒中防治工程专家委员会, 国家卫生健康委脑卒中防治工程委员会医院管理委员会, 国家卫生健康委脑卒中防治工程专家委员会急诊专业委员会. 新型冠状病毒肺炎疫情时期脑卒中绿色通道管理专家共识[J]. 首都医科大学学报, 2020, 41(2): 293-297.